335 related articles for article (PubMed ID: 18162132)
1. Should right ventricle dilatation during exercise have clinical implications in patients with chronic thromboembolic pulmonary hypertension? Case report.
Cotrim C; Loureiro MJ; Miranda R; Almeida S; Almeida AR; Simões O; Cordeiro P; Carrageta M
Cardiovasc Ultrasound; 2007 Dec; 5():50. PubMed ID: 18162132
[TBL] [Abstract][Full Text] [Related]
2. Role of sildenafil in acute posttransplant right ventricular dysfunction: successful experience in 13 consecutive patients.
De Santo LS; Mastroianni C; Romano G; Amarelli C; Marra C; Maiello C; Galdieri N; Della Corte A; Cotrufo M; Caianiello G
Transplant Proc; 2008; 40(6):2015-8. PubMed ID: 18675118
[TBL] [Abstract][Full Text] [Related]
3. Right ventricular diastolic dysfunction and the acute effects of sildenafil in pulmonary hypertension patients.
Gan CT; Holverda S; Marcus JT; Paulus WJ; Marques KM; Bronzwaer JG; Twisk JW; Boonstra A; Postmus PE; Vonk-Noordegraaf A
Chest; 2007 Jul; 132(1):11-7. PubMed ID: 17625080
[TBL] [Abstract][Full Text] [Related]
4. [Hypoxic pulmonary hypertension: modern views on pathogenesis and options for rational pharmacological correction].
Strielkov IeV; Frantsuzova SB; Khromov OS
Fiziol Zh (1994); 2012; 58(2):89-100. PubMed ID: 22873057
[TBL] [Abstract][Full Text] [Related]
5. [Bosentan and chronic thromboembolic pulmonary hypertension].
Tomás C; Callejas-Rubio JL; Ríos-Fernández R; Ortego-Centeno N
Med Clin (Barc); 2007 Nov; 129(16):639. PubMed ID: 18001681
[No Abstract] [Full Text] [Related]
6. [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension].
Kayikçioğlu M; Can LH; Payzin S; Kültürsay H; Soydan I
Anadolu Kardiyol Derg; 2002 Sep; 2(3):262-4. PubMed ID: 12223337
[No Abstract] [Full Text] [Related]
7. Left ventricular function in pulmonary hypertension.
Amano H; Toyoda S; Arikawa T; Inami S; Otani N; Nishi Y; Kitagawa Y; Taguchi I; Abe S; Inoue T
Heart Vessels; 2013 Jul; 28(4):505-9. PubMed ID: 23124961
[TBL] [Abstract][Full Text] [Related]
8. [Treatment with sildenafil, bosentan, or both in children and young people with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome].
Raposo-Sonnenfeld I; Otero-González I; Blanco-Aparicio M; Ferrer-Barba A; Medrano-López C
Rev Esp Cardiol; 2007 Apr; 60(4):366-72. PubMed ID: 17521545
[TBL] [Abstract][Full Text] [Related]
9. Potential role for sildenafil in the management of perioperative pulmonary hypertension and right ventricular dysfunction after cardiac surgery.
Madden BP; Sheth A; Ho TB; Park JE; Kanagasabay RR
Br J Anaesth; 2004 Jul; 93(1):155-6. PubMed ID: 15192009
[No Abstract] [Full Text] [Related]
10. Observational trials in pulmonary arterial hypertension: low scientific evidence but high clinical value.
Hoeper MM
Eur Respir J; 2007 Mar; 29(3):432-4. PubMed ID: 17329488
[No Abstract] [Full Text] [Related]
11. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
[TBL] [Abstract][Full Text] [Related]
12. Bosentan for the treatment of portopulmonary hypertension.
Tempe DK; Datt V; Datta D
Ann Card Anaesth; 2008; 11(2):139-40; author reply 140. PubMed ID: 18603763
[No Abstract] [Full Text] [Related]
13. Therapy with sildenafil or bosentan decreases pulmonary vascular resistance in patients ineligible for heart transplantation because of severe pulmonary hypertension.
Perez-Villa F; Farrero M; Sionis A; Castel A; Roig E
J Heart Lung Transplant; 2010 Jul; 29(7):817-8. PubMed ID: 20363156
[No Abstract] [Full Text] [Related]
14. Pulmonary arterial hypertension: combination therapy in the modern management era.
Sitbon O
Eur Respir Rev; 2010 Dec; 19(118):348-9. PubMed ID: 21119195
[No Abstract] [Full Text] [Related]
15. Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension.
Reichenberger F; Voswinckel R; Enke B; Rutsch M; El Fechtali E; Schmehl T; Olschewski H; Schermuly R; Weissmann N; Ghofrani HA; Grimminger F; Mayer E; Seeger W
Eur Respir J; 2007 Nov; 30(5):922-7. PubMed ID: 17690123
[TBL] [Abstract][Full Text] [Related]
16. Bosentan and sildenafil: should the combination therapy be a valid alternative in childhood to prostacyclin infusion?
Brancaccio G; Toscano A; Bevilacqua M; Di Chiara L; Parisi F
Pediatr Transplant; 2007 Feb; 11(1):110-2. PubMed ID: 17239133
[TBL] [Abstract][Full Text] [Related]
17. Impact of sildenafil therapy on pulmonary arterial hypertension in adults with congenital heart disease.
Lu XL; Xiong CM; Shan GL; Zhu XY; Wu BX; Wu GH; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Zhang DZ; Li WM; Zhang C; Tian HY; Guo YJ; Guo T; Liu HM; Zhang WJ; Gu H; Huang SA; Chen JY; Wu WF; Huang K; Li JJ; He JG
Cardiovasc Ther; 2010 Dec; 28(6):350-5. PubMed ID: 20637015
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonary arterial hypertension following pulmonary thromboembolism].
Wilkens H
Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S328-9. PubMed ID: 17139599
[TBL] [Abstract][Full Text] [Related]
19. The management of Eisenmenger syndrome in the modern treatment era: a case report.
Gatzoulis MA
Eur Respir Rev; 2011 Dec; 20(122):293-6. PubMed ID: 22130823
[No Abstract] [Full Text] [Related]
20. [The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
Humbert M
Rev Med Interne; 2007 Dec; 28 Suppl 4():S273-6. PubMed ID: 17961866
[No Abstract] [Full Text] [Related]
[Next] [New Search]
